 |
TransCode Therapeutics
Last updated: October 09, 2025
CEO - Philippe Calais
USA | Funding: $48.1M (+)
Website: https://www.transcodetherapeutics.com
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
Website: https://www.transcodetherapeutics.com
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
